Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 24 | 2016 | 705 | 1.940 |
Why?
|
| Graft Rejection | 20 | 2020 | 1065 | 1.520 |
Why?
|
| B-Lymphocytes | 12 | 2021 | 726 | 1.170 |
Why?
|
| CD40 Ligand | 9 | 2009 | 69 | 1.110 |
Why?
|
| Transplantation Tolerance | 8 | 2021 | 130 | 0.940 |
Why?
|
| Isoenzymes | 3 | 2013 | 271 | 0.820 |
Why?
|
| Protein Kinase C | 3 | 2013 | 270 | 0.810 |
Why?
|
| Transplantation, Heterologous | 6 | 2004 | 363 | 0.750 |
Why?
|
| Mice, Inbred C57BL | 21 | 2016 | 3111 | 0.700 |
Why?
|
| Obesity | 3 | 2016 | 964 | 0.680 |
Why?
|
| Diet, High-Fat | 2 | 2016 | 114 | 0.660 |
Why?
|
| Isoantibodies | 7 | 2021 | 114 | 0.640 |
Why?
|
| Antibodies, Monoclonal | 9 | 2009 | 1380 | 0.620 |
Why?
|
| T-Lymphocytes | 11 | 2021 | 1200 | 0.620 |
Why?
|
| Mice | 37 | 2021 | 11439 | 0.600 |
Why?
|
| Galactosyltransferases | 7 | 2004 | 40 | 0.580 |
Why?
|
| Jejunum | 1 | 2016 | 79 | 0.560 |
Why?
|
| Mice, Inbred BALB C | 14 | 2020 | 1059 | 0.550 |
Why?
|
| Bile Acids and Salts | 1 | 2016 | 62 | 0.550 |
Why?
|
| Transplantation, Homologous | 12 | 2016 | 996 | 0.540 |
Why?
|
| Pancreas Transplantation | 2 | 2008 | 103 | 0.520 |
Why?
|
| Energy Metabolism | 2 | 2016 | 272 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2016 | 427 | 0.480 |
Why?
|
| Adipose Tissue | 1 | 2016 | 241 | 0.470 |
Why?
|
| Animals | 41 | 2021 | 26706 | 0.460 |
Why?
|
| Gastrointestinal Tract | 2 | 2016 | 191 | 0.460 |
Why?
|
| Spleen | 4 | 2016 | 430 | 0.430 |
Why?
|
| Bone Transplantation | 2 | 2003 | 64 | 0.430 |
Why?
|
| Graft Survival | 8 | 2016 | 885 | 0.410 |
Why?
|
| NF-kappa B | 3 | 2013 | 447 | 0.410 |
Why?
|
| Mice, Knockout | 18 | 2012 | 1944 | 0.410 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 24 | 0.400 |
Why?
|
| Immunologic Memory | 7 | 2016 | 152 | 0.390 |
Why?
|
| Basement Membrane | 1 | 2011 | 54 | 0.380 |
Why?
|
| Abatacept | 4 | 2020 | 83 | 0.370 |
Why?
|
| CpG Islands | 1 | 2009 | 152 | 0.340 |
Why?
|
| Oligonucleotides | 1 | 2009 | 92 | 0.340 |
Why?
|
| Insulin Resistance | 1 | 2011 | 377 | 0.330 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 194 | 0.330 |
Why?
|
| Luminescence | 1 | 2008 | 16 | 0.320 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2006 | 191 | 0.320 |
Why?
|
| Immunoglobulin G | 5 | 2008 | 457 | 0.310 |
Why?
|
| Kidney | 4 | 2011 | 1245 | 0.310 |
Why?
|
| Immune Tolerance | 7 | 2015 | 337 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 203 | 0.290 |
Why?
|
| Mice, Inbred C3H | 5 | 2009 | 371 | 0.290 |
Why?
|
| Isoantigens | 3 | 2020 | 66 | 0.280 |
Why?
|
| Liver | 2 | 2009 | 1229 | 0.280 |
Why?
|
| Insulin-Secreting Cells | 2 | 2006 | 397 | 0.270 |
Why?
|
| Rats, Inbred Lew | 7 | 2008 | 186 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2008 | 568 | 0.260 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 733 | 0.260 |
Why?
|
| Disaccharides | 4 | 2008 | 23 | 0.250 |
Why?
|
| Interferon-gamma | 4 | 2016 | 445 | 0.240 |
Why?
|
| Lymphocytes | 4 | 2009 | 465 | 0.240 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 267 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2008 | 560 | 0.230 |
Why?
|
| Protein Kinase C-theta | 3 | 2013 | 16 | 0.220 |
Why?
|
| Interleukin-10 | 1 | 2003 | 149 | 0.210 |
Why?
|
| Bone Marrow Transplantation | 1 | 2002 | 286 | 0.200 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 141 | 0.200 |
Why?
|
| Blood Glucose | 4 | 2016 | 872 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1271 | 0.200 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2021 | 11 | 0.190 |
Why?
|
| Immunoconjugates | 1 | 2002 | 106 | 0.190 |
Why?
|
| Allografts | 3 | 2021 | 172 | 0.180 |
Why?
|
| Mice, Transgenic | 6 | 2021 | 1557 | 0.180 |
Why?
|
| Germinal Center | 1 | 2020 | 55 | 0.180 |
Why?
|
| Rats | 8 | 2008 | 4004 | 0.180 |
Why?
|
| Fetus | 1 | 2021 | 226 | 0.180 |
Why?
|
| Skin Transplantation | 3 | 2008 | 172 | 0.180 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 132 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2016 | 2243 | 0.170 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2016 | 37 | 0.160 |
Why?
|
| Kinetics | 3 | 2016 | 1513 | 0.160 |
Why?
|
| Adoptive Transfer | 4 | 2008 | 169 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2016 | 3267 | 0.150 |
Why?
|
| CTLA-4 Antigen | 3 | 2009 | 135 | 0.150 |
Why?
|
| Central Tolerance | 1 | 2016 | 8 | 0.140 |
Why?
|
| Gastrointestinal Hormones | 1 | 2016 | 6 | 0.140 |
Why?
|
| Adipokines | 1 | 2016 | 19 | 0.140 |
Why?
|
| Immunosuppressive Agents | 2 | 2016 | 977 | 0.140 |
Why?
|
| Thermogenesis | 1 | 2016 | 34 | 0.140 |
Why?
|
| Adiposity | 1 | 2016 | 70 | 0.140 |
Why?
|
| Receptors, IgG | 2 | 2008 | 52 | 0.140 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 139 | 0.140 |
Why?
|
| Time Factors | 6 | 2016 | 5215 | 0.140 |
Why?
|
| Complement Activation | 2 | 2008 | 81 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2009 | 459 | 0.140 |
Why?
|
| Swine | 5 | 2004 | 559 | 0.130 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2016 | 159 | 0.130 |
Why?
|
| Phenotype | 3 | 2016 | 2389 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2016 | 280 | 0.130 |
Why?
|
| Lipids | 1 | 2016 | 270 | 0.130 |
Why?
|
| Trisaccharides | 3 | 2003 | 12 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 849 | 0.110 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2006 | 225 | 0.110 |
Why?
|
| Rituximab | 1 | 2013 | 116 | 0.110 |
Why?
|
| Listeriosis | 2 | 2015 | 86 | 0.110 |
Why?
|
| Listeria monocytogenes | 2 | 2015 | 91 | 0.110 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2012 | 4 | 0.110 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2009 | 74 | 0.110 |
Why?
|
| Antibody Formation | 3 | 2020 | 171 | 0.110 |
Why?
|
| Transplantation, Heterotopic | 4 | 2009 | 45 | 0.100 |
Why?
|
| Seminiferous Tubules | 1 | 2011 | 8 | 0.100 |
Why?
|
| Epididymis | 1 | 2011 | 18 | 0.100 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2011 | 18 | 0.100 |
Why?
|
| Gastric Bypass | 1 | 2012 | 110 | 0.100 |
Why?
|
| Mice, Inbred NOD | 2 | 2008 | 188 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1596 | 0.090 |
Why?
|
| Weight Loss | 1 | 2012 | 229 | 0.090 |
Why?
|
| Bronchi | 1 | 2011 | 229 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 459 | 0.090 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2008 | 113 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2011 | 751 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 307 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 40 | 0.080 |
Why?
|
| Inflammation | 2 | 2016 | 926 | 0.080 |
Why?
|
| Cytokines | 2 | 2002 | 781 | 0.080 |
Why?
|
| Male | 7 | 2020 | 40995 | 0.080 |
Why?
|
| Luciferases | 1 | 2008 | 119 | 0.080 |
Why?
|
| Immunoglobulin M | 3 | 2002 | 154 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 425 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2009 | 680 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 272 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2011 | 670 | 0.070 |
Why?
|
| Epitopes | 2 | 2004 | 255 | 0.070 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 26 | 0.070 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 228 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2006 | 47 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2003 | 242 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2006 | 1471 | 0.070 |
Why?
|
| Reference Values | 1 | 2006 | 673 | 0.070 |
Why?
|
| Recurrence | 1 | 2008 | 1139 | 0.060 |
Why?
|
| Acute Disease | 2 | 2009 | 827 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2005 | 77 | 0.060 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 144 | 0.060 |
Why?
|
| Histocompatibility | 1 | 2004 | 71 | 0.060 |
Why?
|
| Galactose | 1 | 2003 | 32 | 0.060 |
Why?
|
| Immune Sera | 1 | 2003 | 52 | 0.060 |
Why?
|
| Clonal Deletion | 1 | 2003 | 23 | 0.060 |
Why?
|
| Cloning, Organism | 1 | 2003 | 19 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2003 | 47 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 102 | 0.060 |
Why?
|
| Ricin | 1 | 2002 | 6 | 0.050 |
Why?
|
| beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Female | 10 | 2021 | 44566 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2006 | 1686 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2002 | 80 | 0.050 |
Why?
|
| Mice, Inbred DBA | 1 | 2002 | 148 | 0.050 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 84 | 0.050 |
Why?
|
| Antigens | 1 | 2002 | 228 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2002 | 164 | 0.050 |
Why?
|
| Th2 Cells | 1 | 2002 | 146 | 0.050 |
Why?
|
| Myocardium | 1 | 2004 | 550 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2005 | 512 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 437 | 0.050 |
Why?
|
| Body Weight | 2 | 2016 | 458 | 0.050 |
Why?
|
| Bortezomib | 1 | 2020 | 76 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2003 | 465 | 0.040 |
Why?
|
| Thymocytes | 1 | 2016 | 30 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2002 | 631 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 805 | 0.040 |
Why?
|
| Integrases | 1 | 2016 | 60 | 0.040 |
Why?
|
| Cytidine Deaminase | 1 | 2016 | 43 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2016 | 30 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 63 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Hybridomas | 2 | 2008 | 75 | 0.030 |
Why?
|
| Autoantigens | 1 | 2016 | 127 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 915 | 0.030 |
Why?
|
| Humans | 6 | 2020 | 86656 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2901 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 3035 | 0.030 |
Why?
|
| Immunization | 2 | 2004 | 159 | 0.030 |
Why?
|
| Heart | 1 | 2016 | 557 | 0.030 |
Why?
|
| Models, Animal | 2 | 2004 | 264 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 2002 | 250 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 1853 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 166 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 366 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 866 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 29 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 52 | 0.020 |
Why?
|
| Bystander Effect | 1 | 2008 | 12 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2008 | 26 | 0.020 |
Why?
|
| Hemolysin Proteins | 1 | 2008 | 34 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2008 | 71 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2065 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 48 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 2476 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2008 | 97 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2008 | 148 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2008 | 82 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2008 | 111 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 92 | 0.020 |
Why?
|
| Interferon Type I | 1 | 2008 | 175 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2008 | 179 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 971 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2006 | 254 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2005 | 37 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 306 | 0.020 |
Why?
|
| Alkynes | 1 | 2005 | 17 | 0.020 |
Why?
|
| Uridine | 1 | 2005 | 56 | 0.020 |
Why?
|
| Regeneration | 1 | 2006 | 147 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2006 | 160 | 0.020 |
Why?
|
| Nitriles | 1 | 2005 | 149 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 538 | 0.020 |
Why?
|
| Membranes | 1 | 2004 | 36 | 0.020 |
Why?
|
| Stem Cells | 1 | 2006 | 358 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2003 | 39 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 319 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2003 | 20 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2003 | 49 | 0.010 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2003 | 15 | 0.010 |
Why?
|
| Antibody Affinity | 1 | 2003 | 38 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2839 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 2003 | 62 | 0.010 |
Why?
|
| Lymphocyte Transfusion | 1 | 2002 | 41 | 0.010 |
Why?
|
| Antigens, Heterophile | 1 | 2002 | 6 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 8476 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 219 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2003 | 255 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 128 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 1041 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2004 | 543 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2004 | 581 | 0.010 |
Why?
|
| Antibodies | 1 | 2002 | 352 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 731 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 666 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2003 | 307 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 705 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 1214 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1689 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 25027 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 25648 | 0.010 |
Why?
|